PASSAGE BIO INC (PASG) Stock Income Statement
NASDAQ:PASG - Nasdaq - US7027121000 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 60.94M | 65.17M | 103.00M | 138.39M | 185.73M | |||
| Research and Development | 36.38M | 40.18M | 61.42M | 89.05M | 125.67M | |||
| Selling, General, and Administrative Expenses | 24.56M | 24.99M | 41.58M | 49.34M | 60.06M | |||
| Operating Income | -60.94M | -65.17M | -103.00M | -138.39M | -185.73M | |||
| Interest Income/Expense | 3.80M | 4.30M | 5.60M | 2.27M | 340.00K | |||
| Other Income/Expense | 1.55M | 1.33M | 727.00K | N/A | N/A | |||
| Non Recurring Items | -7.87M | -5.23M | -5.39M | N/A | N/A | |||
| Income Before Taxes | -63.46M | -64.77M | -102.06M | -136.13M | -185.39M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -63.46M | -64.77M | -102.06M | -136.13M | -185.39M | |||
| EBITDA | -58.46M | -62.09M | -99.28M | -134.71M | -184.19M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.03 | -1.07 | -1.86 | -2.50 | -3.48 | |||
| Non GAAP EPS | -1.02 | -1.07 | -1.86 | -2.50 | -3.48 | |||
| Statistics | ||||||||
All data in USD